Mak they made statement costs were $400k needed to comercialise in todays ann. As it is a joint venture VIL wont be up for all of that maybe 50% not a big call. The unfortunate part of the day is price gapped up too high, even though a positive ann it wasnt positive enough to hold such gains.
Fell back on pretty light volume, I would suspect that tommorrow will be viewed as over sold and a technical move back to maybe just over the .05 area.
Overall was a bit of a dissapointing day however there is plenty of potential for more anns and upgrades
- Forums
- ASX - By Stock
- VIL
- why it is on red?
why it is on red?, page-12
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VIL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online